P2X receptors are differentially expressed on vasopressin- and oxytocin-containing neurons in the supraoptic and paraventricular nuclei of rat hypothalamus.
In the present study, the distribution of P2X receptor protein and colocalization of P2X receptors with vasopressin and oxytocin in the supraoptic and paraventricular nuclei of rat hypothalamus was studied using double-labeling fluorescence immunohistochemistry. The results showed that vasopressin-containing neurons expressed P2X(2), P2X(4), P2X(5) and P2X(6) receptor and oxytocin-containing neurons expressed P2X(2), P2X(4) and P2X(5) receptors in the supraoptic nucleus. In the paraventricular nucleus, vasopressin-containing neurons expressed P2X(4), P2X(5) and P2X(6) receptors, while oxytocin-containing neurons expressed P2X(4) receptors. This study provides the first evidence that P2X receptor subunits are differentially expressed on vasopressin- and oxytocin-containing neurons in the supraoptic and paraventricular nuclei, and hence, provides a substantial neuroanatomical basis for possible functional interactions between the purinergic and vasopressinergic systems, and the purinergic and oxytocinergic systems in the rat hypothalamus.
Guo
Wei
W
Department of Neurobiology, Second Military Medical University, 200433, Shanghai, People's Republic of China.
Sun
Jihu
J
Xu
Xiaohui
X
Bunstock
Geoffrey
G
He
Cheng
C
Xiang
Zhenghua
Z
D000818:Animals; D007150:Immunohistochemistry; D009474:Neurons / Q000737:chemistry / Q000378:metabolism*; D010121:Oxytocin / Q000032:analysis* / Q000378:metabolism; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D018048:Receptors, Purinergic P2 / Q000032:analysis / Q000378:metabolism*; D058469:Receptors, Purinergic P2X; D013495:Supraoptic Nucleus / Q000378:metabolism*; D014667:Vasopressins / Q000032:analysis* / Q000378:metabolism
D018048:Receptors, Purinergic P2; D058469:Receptors, Purinergic P2X; D014667:Vasopressins; D010121:Oxytocin
Cell Mol Life Sci. 2007 Jun;64(12):1471-83
17375261
Neuroscience. 1980;5(7):1351-6
7402474
Neuroscience. 2003;121(2):411-9
14521999
Physiol Rev. 2007 Apr;87(2):659-797
17429044
Exp Physiol. 2006 Mar;91(2):403-11
16299016
Physiol Rev. 2002 Oct;82(4):1013-67
12270951
Mol Pharmacol. 1995 Oct;48(4):569-73
7476880
Brain Res. 2006 Jul 12;1099(1):56-63
16765918
Trends Pharmacol Sci. 2006 Mar;27(3):166-76
16487603
Br J Pharmacol. 2002 Apr;135(8):2047-55
11959809
J Endocrinol. 1999 Mar;160(3):343-50
10076181
J Neurocytol. 1999 Jun;28(6):495-504
10767101
Brain Res. 1998 Dec 7;813(2):390-7
9838201
Brain Res. 1994 Apr 4;641(2):249-56
8012826
J Neurosci. 2000 Dec 1;20(23):8868-75
11102496
J Neurosci. 1996 Apr 15;16(8):2495-507
8786426
Brain Res. 1975 Aug 8;93(2):363-6
1174976
J Endocrinol. 1975 Dec;67(3):461-2
1206330
Neuropharmacology. 1992 Jun;31(6):585-92
1407398
J Physiol. 1999 Jan 15;514 ( Pt 2):351-67
9852319
Neuroscience. 2001;106(3):621-31
11591462
Neuroscience. 1996 Aug;73(3):637-42
8809784
Neuroscience. 1981;6(4):619-43
7017456
Pflugers Arch. 2006 Aug;452(5):513-37
16649055
Brain Res. 1993 Apr 2;607(1-2):341-4
8481811
Mol Pharmacol. 2007 Dec;72(6):1447-56
17785580
J Physiol. 1995 Dec 15;489 ( Pt 3):805-11
8788944
Histochem Cell Biol. 2006 Oct;126(4):453-63
16612582
Prog Brain Res. 1983;60:115-22
6665132
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3684-8
8622997
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):8063-7
8755603
J Virol Methods. 1998 Jul;73(1):89-97
9705180
Brain Res. 1992 Oct 30;594(2):244-52
1450950
J Comp Neurol. 1999 Apr 28;407(1):11-32
10213185
Histochem Cell Biol. 2005 Nov;124(5):379-90
16136347
J Physiol. 1998 Aug 15;511 ( Pt 1):89-103
9679166